America’s Health Insurance Plans President Matt Eyles declined to say Friday (Sept. 13) whether insurers oppose Medicare drug price negotiation, even though the trade group used to oppose the policy without conditions. Those following the drug pricing debate say AHIP’s shift to a nuanced approach on government price negotiation is a significant development. Although insurers and brand drug makers have forever been at odds on many policies related to drug prices, AHIP at least provided pharma cover on government price...